Skip to content
★ Sign in to follow
JW

Justin W. Yorke

Board Director
Director
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
18
Company
1
▲ Purchases (2 ops.)
€29k
▼ Sales (5 ops.)
€176k

Latest filing published 31 Jan 2025 for Processa Pharmaceuticals, Inc., €9,447.

Filing timeline

BuySale
Justin W. Yorke

Insider track record

Disclosed buys
2
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-43.2%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Justin W. Yorke: trading record in brief

All filings by Justin W. Yorke on record concern Processa Pharmaceuticals, Inc., in the capacity of board member. Over a trading history stretching from 13 April 2021 to 27 January 2025, the count stands at 18 filings.

Market trades split into 2 purchases (€29k) and 5 sales (€176k). The net balance comes to €147k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants and 2 option exercises. So far in 2025, the count stands at 1 purchase and no sales.

The record was last updated on 31 January 2025 with an open-market purchase (€9,447) in Processa Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Justin W. Yorke

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations